Research ArticleLaboratory Studies
In Vitro and In Vivo Evaluation of Copper-64-Octreotide Conjugates
Carolyn J. Anderson, Tammy S. Pajeau, W. Barry Edwards, Elizabeth L.C. Sherman, Buck E. Rogers and Michael J. Welch
Journal of Nuclear Medicine December 1995, 36 (12) 2315-2325;
Carolyn J. Anderson
Tammy S. Pajeau
W. Barry Edwards
Elizabeth L.C. Sherman
Buck E. Rogers
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
In Vitro and In Vivo Evaluation of Copper-64-Octreotide Conjugates
Carolyn J. Anderson, Tammy S. Pajeau, W. Barry Edwards, Elizabeth L.C. Sherman, Buck E. Rogers, Michael J. Welch
Journal of Nuclear Medicine Dec 1995, 36 (12) 2315-2325;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Improving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE
- Targeting Somatostatin Receptors: Preclinical Evaluation of Novel 18F-Fluoroethyltriazole-Tyr3-Octreotate Analogs for PET
- 68Ga-Labeled Peptides in Tumor Imaging
- Subcellular Localization of Radiolabeled Somatostatin Analogues: Implications for Targeted Radiotherapy of Cancer
- In Vivo Evaluation of Pretargeted 64Cu for Tumor Imaging and Therapy
- 64Cu-TETA-Octreotide as a PET Imaging Agent for Patients with Neuroendocrine Tumors
- Radiotherapy and Dosimetry of 64Cu-TETA-Tyr3-Octreotate in a Somatostatin Receptor-positive, Tumor-bearing Rat Model
- Somatostatin Receptors in the Diagnosis and Therapy of Neuroendocrine Tumors